Elumalai P, Brindha Mercy A, Arunkamar R, Sharmila G, Bhat F, Balakrishnan S
Cell Prolif. 2014; 47(6):540-52.
PMID: 25377085
PMC: 6495824.
DOI: 10.1111/cpr.12148.
El Hajj E, El Hajj M, Voloshenyuk T, Mouton A, Khoutorova E, Molina P
Alcohol Clin Exp Res. 2013; 38(2):448-56.
PMID: 24033327
PMC: 4080812.
DOI: 10.1111/acer.12239.
Saitou T, Itano K, Hoshino D, Koshikawa N, Seiki M, Ichikawa K
Theor Biol Med Model. 2012; 9:33.
PMID: 22863329
PMC: 3512525.
DOI: 10.1186/1742-4682-9-33.
Gilliver S, Emmerson E, Campbell L, Chambon P, Hardman M, Ashcroft G
Am J Pathol. 2010; 176(6):2707-21.
PMID: 20448060
PMC: 2877833.
DOI: 10.2353/ajpath.2010.090432.
Waite A, Gilliver S, Masterson G, Hardman M, Ashcroft G
Br J Anaesth. 2010; 104(6):768-73.
PMID: 20418532
PMC: 2867659.
DOI: 10.1093/bja/aeq093.
Role of the netrin-like domain of procollagen C-proteinase enhancer-1 in the control of metalloproteinase activity.
Bekhouche M, Kronenberg D, Vadon-Le Goff S, Bijakowski C, Lim N, Font B
J Biol Chem. 2010; 285(21):15950-9.
PMID: 20207734
PMC: 2871463.
DOI: 10.1074/jbc.M109.086447.
The C-terminal domains of ADAMTS-4 and ADAMTS-5 promote association with N-TIMP-3.
Troeberg L, Fushimi K, Scilabra S, Nakamura H, Dive V, Thogersen I
Matrix Biol. 2009; 28(8):463-9.
PMID: 19643179
PMC: 2835468.
DOI: 10.1016/j.matbio.2009.07.005.
Advances in animal cell recombinant protein production: GS-NS0 expression system.
Barnes L, Bentley C, Dickson A
Cytotechnology. 2008; 32(2):109-23.
PMID: 19002973
PMC: 3449689.
DOI: 10.1023/A:1008170710003.
Specialized podosome- or invadopodia-like structures (PILS) for focal trabecular meshwork extracellular matrix turnover.
Aga M, Bradley J, Keller K, Kelley M, Acott T
Invest Ophthalmol Vis Sci. 2008; 49(12):5353-65.
PMID: 18641286
PMC: 2683617.
DOI: 10.1167/iovs.07-1666.
Acrolein-activated matrix metalloproteinase 9 contributes to persistent mucin production.
Deshmukh H, Shaver C, Case L, Dietsch M, Wesselkamper S, Hardie W
Am J Respir Cell Mol Biol. 2007; 38(4):446-54.
PMID: 18006877
PMC: 2274947.
DOI: 10.1165/rcmb.2006-0339OC.
MT1-MMP hemopexin domain exchange with MT4-MMP blocks enzyme maturation and trafficking to the plasma membrane in MCF7 cells.
Atkinson S, Roghi C, Murphy G
Biochem J. 2006; 398(1):15-22.
PMID: 16686598
PMC: 1525013.
DOI: 10.1042/BJ20060243.
Selective regulation of MMP and TIMP mRNA levels in tree shrew sclera during minus lens compensation and recovery.
Siegwart Jr J, Norton T
Invest Ophthalmol Vis Sci. 2005; 46(10):3484-92.
PMID: 16186323
PMC: 1987367.
DOI: 10.1167/iovs.05-0194.
Identification, purification and characterization of matrix metalloproteinase-2 in bovine pulmonary artery smooth muscle plasma membrane.
Das S, Mandal M, Mandal A, Chakraborti T, Chakraborti S
Mol Cell Biochem. 2004; 258(1-2):73-89.
PMID: 15030172
DOI: 10.1023/b:mcbi.0000012838.41792.d2.
TIMP-2 (tissue inhibitor of metalloproteinase-2) regulates MMP-2 (matrix metalloproteinase-2) activity in the extracellular environment after pro-MMP-2 activation by MT1 (membrane type 1)-MMP.
Bernardo M, Fridman R
Biochem J. 2003; 374(Pt 3):739-45.
PMID: 12755684
PMC: 1223627.
DOI: 10.1042/BJ20030557.
Tailoring tissue inhibitor of metalloproteinases-3 to overcome the weakening effects of the cysteine-rich domains of tumour necrosis factor-alpha converting enzyme.
Lee M, Dodds P, Verma V, Maskos K, Knauper V, Murphy G
Biochem J. 2003; 371(Pt 2):369-76.
PMID: 12556225
PMC: 1223312.
DOI: 10.1042/BJ20021538.
The cysteine-rich domain regulates ADAM protease function in vivo.
Smith K, Gaultier A, Cousin H, Alfandari D, White J, DeSimone D
J Cell Biol. 2002; 159(5):893-902.
PMID: 12460986
PMC: 2173380.
DOI: 10.1083/jcb.200206023.
Molecular determinants of metalloproteinase substrate specificity: matrix metalloproteinase substrate binding domains, modules, and exosites.
Overall C
Mol Biotechnol. 2002; 22(1):51-86.
PMID: 12353914
DOI: 10.1385/MB:22:1:051.
Structural insight into the complex formation of latent matrix metalloproteinase 2 with tissue inhibitor of metalloproteinase 2.
Morgunova E, Tuuttila A, Bergmann U, Tryggvason K
Proc Natl Acad Sci U S A. 2002; 99(11):7414-9.
PMID: 12032297
PMC: 124245.
DOI: 10.1073/pnas.102185399.
Expression of transforming growth factor-beta 1 by pancreatic stellate cells and its implications for matrix secretion and turnover in chronic pancreatitis.
Benyon R, Walker F, McCrudden P, Pender S, Williams E, Johnson P
Am J Pathol. 2002; 160(5):1787-98.
PMID: 12000730
PMC: 1850856.
DOI: 10.1016/s0002-9440(10)61125-x.
Engineering N-terminal domain of tissue inhibitor of metalloproteinase (TIMP)-3 to be a better inhibitor against tumour necrosis factor-alpha-converting enzyme.
Lee M, Verma V, Maskos K, Nath D, Knauper V, Dodds P
Biochem J. 2002; 364(Pt 1):227-34.
PMID: 11988096
PMC: 1222565.
DOI: 10.1042/bj3640227.